Log in  First Connection?

VirusArchives

Decline of HIV infection: legacy of tenofovir (A. Holý) and rilpivirine (P. Janssen)
Virus
 1 min.

 Published on 28/05/2026 |  Original article (Full-text)  | Erik De Clercq et al. | Future Virology 2026; aop:10.1080/17460794.2026.2677363

Among the wide variety of antivirals that have been developed for the treatment of human immunodeficiency virus (HIV) infections and acquired immunodeficiency syndrome (AIDS), two stand out: tenofovir and rilpivirine. The names unmistakenly associated with the discovery of these two compounds, are Antonín...

The potential roles of IgG glycosylation in the development of non-communicable comorbidities in people with HIV
Virus
 1 min.

 Published on 21/05/2026 |  Original article (Full-text)  | Fangqi Fu et al. | Future Virology 2026; 21(4): 289-298

The introduction of effective antiretroviral therapy (ART) has transformed Human Immunodeficiency Virus (HIV) infection from a once-fatal diagnosis into a manageable chronic condition, with life expectancy in people with HIV approaching that of the general population. However, this extended lifespan...

Cardiorespiratory fitness and physical activity and risk of SARS-CoV-2 and COVID-19 hospitalization: the HUNT study
Virus
 5 min.

 Published on 14/05/2026 |  Original article (Full-text)  | Eriksen Espen Alexander et al. | BMC Infectious Diseases 2026; 26(1): 396

Since its initial outbreak in March 2020, the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and the coronavirus disease 2019 (COVID-19) pandemic has caused more than 776 million confirmed cases of infections and more than 7 million deaths worldwide (as of 25th of September 2024) [1, 2]....

Real-world comparative effectiveness of SARS-CoV-2 primary vaccination campaigns against SARS-CoV-2 infections: a federated observational study emulating a target trial in three nations
Virus
 1 min.

 Published on 07/05/2026 |  Original article (Full-text)  | Marjan Meurisse et al. | European Journal of Public Health. Volume 36(2).

To assess the impact of large-scale severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination campaigns in real-world settings across regions, we performed a reproducible cross-border comparison of the real-world effectiveness of primary vaccination in preventing SARS-CoV-2 infections...

Cell-free HPV DNA as a complementary biomarker to imaging in HPV-associated oropharyngeal squamous cell carcinoma: a narrative synthesis of key studies
Virus
 1 min.

 Published on 30/04/2026 |  Original article (Full-text)  | Ingeborg Tinhofer et al. | Expert Review of Molecular Diagnostics 2026; 26(3): 257-266

Human papillomavirus (HPV)–associated oropharyngeal squamous cell carcinoma (OPSCC) represents a biologically distinct disease entity with superior prognosis compared with HPV-negative head and neck cancers. While imaging-based strategies, particularly those monitoring hypoxia, have emerged as...